MYLES DAVID C. (Chief Development Officer) sold 8.5% of their position (51K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.55M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/23/2025ACC: 0001831216-25-000004
Officer· Chief Development Officer
Since Nov 2020
-60K
Net shares
Net seller
$1.55M
Total sold
3
Open market trades
0B · 3S
4
Total transactions
60K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1.23K
Price / share
$28.08
Trade value
$34.40K
% of position
0.2%
12/19/2025
602.88K→601.66K
Common Stock
Direct
Shares
−43.73K
Price / share
$30.40
Trade value
$1.33M
% of position
7.3%
12/19/2025
601.66K→557.93K
Common Stock
Direct
Shares
−6.05K
Price / share
$31.39
Trade value
$189.78K
% of position
1.1%
12/19/2025
557.93K→551.88K
Common Stock
Direct
Shares
−9K
Price / share
—
Trade value
—
% of position
1.6%
12/19/2025
551.88K→542.88K
Total
Net shares
−60K
Net value
-$1.55M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −1.23K | $28.08 | $34.40K | 0.2% | 602.88K | 601.66K |
| Common Stock Direct | 12/19/2025 | S · Sale | −43.73K | $30.40 | $1.33M | 7.3% | 601.66K | 557.93K |
| Common Stock Direct | 12/19/2025 | S · Sale | −6.05K | $31.39 | $189.78K | 1.1% | 557.93K | 551.88K |
| Common Stock Direct | 12/19/2025 | G · Gift | −9K | — | — | 1.6% | 551.88K | 542.88K |
| Total | −60K | -$1.55M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned12.83K
Common Stock
IndirectShares owned154.85K
Total
167.68K indirect167.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.83K | Indirect |
| Common Stock | 154.85K | Indirect |
| Total | 167.68K | 167.68K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported